Robert Miller: Defining Musical Toxicity and its Frequency
Robert Miller, Chief Medical Science Officer at CancerLinQ shared on LinkedIn about recent paper by Jessica F. Burlile et al., titled “Musician’s Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency” published on JCO Oncology Practice.
Authors: Jessica F. Burlile, Joshua D. Cameron, Heather J. Gunn, Nicole L. Larson, Jennifer L. Bradt, Judy C. Boughey, Mary M. Mrdutt, Fergus J. Couch, Janet E. Olson, Valerie Cangie, Shawna Ehlers, Yasamin Sharifzadeh, Kathryn J. Ruddy, Dean A. Shumway, Charles L. Loprinzi, and Elizabeth J. Cathcart-Rake.
“I’m an oncologist and a musician and can’t say I had ever heard of acute musical toxicity from cancer treatment being formally described and studied before. But of course hardly surprising that it exists (neuropathy, fatigue, cognitive impacts, etc.). Bravo to the Mayo Clinic authors for doing this patient-centric study and the musical patients who participated. Table 2 (JCO Oncology Practice article is open access so no paywall) showing incidence of toxicities is illuminating.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023